| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 7e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |